UnitedHealth Group raised its full-year 2026 adjusted earnings outlook to at least $20.50 per share after third-quarter results exceeded estimates. The insurer cited improved medical cost management and operational efficiencies.
UnitedHealth Group reported third-quarter earnings that surpassed Wall Street expectations on Tuesday, prompting the nation’s largest private insurer to raise its full-year profit outlook. The company now expects fiscal 2026 adjusted earnings of at least $20.50 per share, an increase from its previous guidance of $19.50 to $20 per share.
For the third quarter, UnitedHealth reported adjusted earnings per share of $4.69, beating the analyst consensus of $4.14 per share according to LSEG data. This figure represents a significant increase from the $2.92 per share adjusted earnings reported in the same period a year earlier. Net income attributable to shareholders rose to $4.1 billion, or $4.56 per share, compared with $2.35 billion, or $2.59 per share, in the third quarter of 2025.
Total revenue for the quarter came in at $112.69 billion, exceeding the expected $111.40 billion, though it represented a slight decline from the $113.16 billion reported a year prior. Operating earnings increased 52% to $6.6 billion, driven by improved performance in both the UnitedHealthcare insurance division and the Optum healthcare services unit.
A key factor in the improved profitability was a reduction in the medical care ratio, which measures medical expenses paid relative to premiums collected. The ratio improved to 88.4% for the third quarter, down from 89.9% in the year-ago period and below the analyst expectation of 89.9%. A lower ratio indicates that the company retained a larger portion of premiums for profit and operations.
CFO Wayne DeVeydt noted that while the ratio improved, medical costs remain elevated compared to historical norms. "I think it’s something we should keep an eye on. I think you’ll see that our medical care ratio has improved quite a bit, but I don’t want that to be misleading in terms of [medical cost trends]," DeVeydt said in an interview with CNBC.
The company attributed the improvement to plan design changes, revised product pricing, and a $610 million favorable reserve adjustment. However, DeVeydt stated that the independent dispute resolution (IDR) process under the No Surprises Act is adding at least 100 basis points to total medical costs. He also highlighted that costs for inpatient services and specialty pharmacy drugs remain high.
UnitedHealth is actively managing its membership base to improve margins, a strategy that has resulted in declines across several segments. Since the end of 2025, 935,000 members have exited the Medicare Advantage business. Additionally, employer-sponsored health plan membership fell by 165,000 people, and Medicaid rolls decreased by 85,000 due to eligibility changes.
The company is also leveraging technology to reduce administrative burdens and control costs. UnitedHealth is rolling out AI-powered ambient listening tools to assist physicians, a move the company says helps free up time for patient visits. According to DeVeydt, acute hospital admissions among members fell 15% year over year through the third quarter, while home health admissions rose 10%, suggesting a shift toward lower-cost care settings.
"You’re finding more members are actually getting into a lower-cost care environment, but more importantly, they’re getting into the care environment they actually want to be in," DeVeydt said. "So we think we’re really balancing both the quality and the cost."
The raised outlook signals that UnitedHealth’s turnaround strategy, which includes exiting unprofitable contracts and investing in value-based care, is gaining traction after a period of operational challenges. The company’s ability to manage medical costs while navigating regulatory pressures like the No Surprises Act will be critical for sustaining profitability in the coming years. Investors are watching closely to see if these efficiency gains can offset the declining membership numbers in key insurance segments.
Sources
This article was drafted with AI assistance and checked against the sources above. Company claims are reported as claims. Cover image is AI-generated.
The day's checked news, by email
One short email a day with the top stories. Free, and you can unsubscribe in one click.
Or follow for the latest news:
CVS Pharmacy Inc. agreed to pay $315 million to resolve a Justice Department lawsuit alleging it unlawfully dispensed medically unnecessary opioid prescriptions. The settlement requires new safeguards but admits no wrongdoing.
Stelco has begun laying off workers in Hamilton, rejecting federal accusations of breaching its acquisition agreement. The company cites U.S. tariffs as the cause, while Ottawa threatens legal action.
